Saudi Arabia Antifungal Drugs Market Size & Outlook
Saudi Arabia antifungal drugs market, 2018-2030 (US$M)
Related Markets
Saudi Arabia antifungal drugs market highlights
- The Saudi Arabia antifungal drugs market generated a revenue of USD 220.7 million in 2023 and is expected to reach USD 327.2 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
- In terms of segment, azoles was the largest revenue generating drug class in 2023.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
Antifungal drugs market data book summary
| Market revenue in 2023 | USD 220.7 million |
| Market revenue in 2030 | USD 327.2 million |
| Growth rate | 5.8% (CAGR from 2023 to 2030) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.4% of the global antifungal drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia antifungal drugs market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 327.2 million by 2030.
Azoles was the largest segment with a revenue share of 47.8% in 2023. Horizon Databook has segmented the Saudi Arabia antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Food & Drug Authority is responsible for pharmaceutical approvals and regulations in the country . The submission process has three steps—online application, product file delivery, and drug samples .
After this, for marketing approval, the application has to undergo validation, assessment, testing, inspection, pricing, and product licensing. If the application gets rejected, the applicant can file an appeal against the decision that has been made in 60 days.
The Ministry of Health (MOH) is the main government organization responsible for providing healthcare services to the people, which are preventive, curative, and rehabilitative. The Ministry has a network of medical facilities all across the Kingdom that offer primary healthcare services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia antifungal drugs market size, by drug class, 2018-2030 (US$M)
Saudi Arabia Antifungal Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
